Leishmaniasis impact and treatment access |
| |
Authors: | den Boer M Argaw D Jannin J Alvar J |
| |
Institution: | Leishmaniasis Control Programme, WHO/IDM. Av. Appia, Geneva, Switzerland. |
| |
Abstract: | According to disease burden estimates, leishmaniasis ranks third in disease burden in disability-adjusted life years caused by neglected tropical diseases and is the second cause of parasite-related deaths after malaria; but for a variety of reasons, it is not receiving the attention that would be justified seeing its importance. This is especially apparent in the unnecessarily and unacceptably poor access to timely and appropriate treatment for patients. To our knowledge, this is the first publication that addresses the major issues associated with poor access to drugs for leishmaniasis and that outlines a number of feasible and practical solutions. |
| |
Keywords: | Access to care access to drugs drugs leishmaniasis |
本文献已被 ScienceDirect PubMed 等数据库收录! |